Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -9.11 is 174% below its 4-year average of -3.32, near the low end of its 4-year range (-10.04–2.67).
309.44% below its 12-month average of -2.23.
Reported quarterly EPS; no daily interpolation. Q4 FY2026 (2026-06-30): -0.38.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 7 comparable quarters.
EARNINGS PER SHARE (EPS)
-9.11
EARNINGS PER SHARE (EPS) AVG TTM
-2.23
EARNINGS PER SHARE (EPS) AVG 3Y
-1.64
EARNINGS PER SHARE (EPS) AVG 5Y
N/A
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
-309.44%
CURRENT VS 3Y AVG
-455.49%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Lite Strategy, Inc.
Market Cap
$47.12M
Earnings Per Share (EPS)
-9.11
TTM Avg
-2.23
3Y Avg
-1.64
5Y Avg
N/A
Market Cap
$48.22M
Earnings Per Share (EPS)
-2.83
TTM Avg
-3.12
3Y Avg
-4.06
5Y Avg
-22.86
Market Cap
$49.44M
Earnings Per Share (EPS)
-0.26
TTM Avg
-0.51
3Y Avg
-0.97
5Y Avg
-1.13
Market Cap
$46.14M
Earnings Per Share (EPS)
0.69
TTM Avg
-0.78
3Y Avg
-1.53
5Y Avg
-2.71
Market Cap
$49.20M
Earnings Per Share (EPS)
-3.55
TTM Avg
-4.16
3Y Avg
-5.92
5Y Avg
-5.28
Market Cap
$44.73M
Earnings Per Share (EPS)
-0.73
TTM Avg
-1.48
3Y Avg
-1.47
5Y Avg
-1.37
Market Cap
$44.10M
Earnings Per Share (EPS)
-1.70
TTM Avg
-1.03
3Y Avg
-1.29
5Y Avg
-1.28
Market Cap
$50.64M
Earnings Per Share (EPS)
-0.69
TTM Avg
-1.98
3Y Avg
-1.79
5Y Avg
-1.67
Market Cap
$43.99M
Earnings Per Share (EPS)
-1.68
TTM Avg
0.78
3Y Avg
0.08
5Y Avg
-0.02
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Lite Strategy, Inc. (LITS) | $47.12M | -9.11 | -2.23 | -1.64 | N/A |
| Celularity Inc. (CELU)vs › | $48.22M | -2.83 | -3.12 | -4.06 | -22.86 |
| Microbot Medical Inc. (MBOT)vs › | $49.44M | -0.26 | -0.51 | -0.97 | -1.13 |
| DarioHealth Corp. (DRIO)vs › | $46.14M | 0.69 | -0.78 | -1.53 | -2.71 |
| Clene Inc. (CLNN)vs › | $49.20M | -3.55 | -4.16 | -5.92 | -5.28 |
| Werewolf Therapeutics, Inc. (HOWL)vs › | $44.73M | -0.73 | -1.48 | -1.47 | -1.37 |
| Nano-X Imaging Ltd. (NNOX)vs › | $44.10M | -1.70 | -1.03 | -1.29 | -1.28 |
| INmune Bio, Inc. (INMB)vs › | $50.64M | -0.69 | -1.98 | -1.79 | -1.67 |
| BioStem Technologies, Inc. (BSEM)vs › | $43.99M | -1.68 | 0.78 | 0.08 | -0.02 |
| biote Corp. (BTMD)vs › | $52.49M | 0.12 | 0.48 | 0.24 | 1.52 |
Trailing EPS (TTM)
$-9.11
Forward EPS (Est.)
$-1.56
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2026-06-30 | -2.06 |
| 2025-06-30 | -2.39 |
| 2024-06-30 | 2.67 |
| 2023-06-30 | -4.78 |
| 2022-06-30 | -10.04 |
